MT-ND2 (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: MT-ND2 (mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2) Homo sapiens
Analyze
Symbol: MT-ND2
Name: mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2
RGD ID: 1350157
HGNC Page HGNC
Description: Enables NADH dehydrogenase (ubiquinone) activity. Involved in mitochondrial electron transport, NADH to ubiquinone and mitochondrial respiratory chain complex I assembly. Part of mitochondrial respiratory chain complex I. Implicated in Leber hereditary optic neuropathy; myocardial infarction; neurodegenerative disease (multiple); and urinary bladder cancer; INTERACTS WITH 17beta-hydroxy-17-methylestra-4,9,11-trien-3-one; 3-isobutyl-1-methyl-7H-xanthine; aristolochic acid.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: mitochondrially encoded NADH dehydrogenase 2; MTND2; NADH dehydrogenase subunit 2
RGD Orthologs
Mouse
Rat
Dog
Pig
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38.p13 EnsemblMT4,470 - 5,511 (+)EnsemblGRCh38hg38GRCh38
GRCh38MT4,470 - 5,511 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh37MT4,470 - 5,511 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36MT4,471 - 5,512 (+)NCBINCBI36hg18NCBI36


Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component

Molecular Function

Phenotype Annotations     Click to see Annotation Detail View

Human Phenotype
Abnormal mitochondria in muscle tissue  (IAGP)
Abnormal renal tubule morphology  (IAGP)
Abnormal speech prosody  (IAGP)
Abnormality of Krebs cycle metabolism  (IAGP)
Apnea  (IAGP)
Arrhythmia  (IAGP)
Ataxia  (IAGP)
Bilateral tonic-clonic seizure  (IAGP)
Blindness  (IAGP)
Blurred vision  (IAGP)
Bulbar signs  (IAGP)
Cardiac conduction abnormality  (IAGP)
Central retinal vessel vascular tortuosity  (IAGP)
Central scotoma  (IAGP)
Centrocecal scotoma  (IAGP)
Chorea  (IAGP)
Decreased activity of mitochondrial complex I  (IAGP)
Demyelinating peripheral neuropathy  (IAGP)
Developmental regression  (IAGP)
Diabetes mellitus  (IAGP)
Dilated cardiomyopathy  (IAGP)
Dyskinesia  (IAGP)
Dysphagia  (IAGP)
Dystonia  (IAGP)
Encephalopathy  (IAGP)
Episodic respiratory distress  (IAGP)
Episodic vomiting  (IAGP)
Failure to thrive  (IAGP)
Feeding difficulties  (IAGP)
Fetal distress  (IAGP)
Fever  (IAGP)
Focal T2 hyperintense basal ganglia lesion  (IAGP)
Focal T2 hyperintense brainstem lesion  (IAGP)
Gait ataxia  (IAGP)
Generalized myoclonic seizure  (IAGP)
Global developmental delay  (IAGP)
Hepatic failure  (IAGP)
Hepatomegaly  (IAGP)
Heterogeneous  (IAGP)
Hyperalaninemia  (IAGP)
Hyperreflexia  (IAGP)
Hypertrophic cardiomyopathy  (IAGP)
Hyperventilation  (IAGP)
Hypoglycemia  (IAGP)
Hyporeflexia  (IAGP)
Hypothermia  (IAGP)
Hypotonia  (IAGP)
Incomplete penetrance  (IAGP)
Increased CSF lactate  (IAGP)
Increased serum lactate  (IAGP)
Increased serum pyruvate  (IAGP)
Infantile muscular hypotonia  (IAGP)
Infantile spasms  (IAGP)
Intrauterine growth retardation  (IAGP)
Lactic acidosis  (IAGP)
Lacticaciduria  (IAGP)
Leber optic atrophy  (IAGP)
Lethargy  (IAGP)
Leukodystrophy  (IAGP)
Leukoencephalopathy  (IAGP)
Low plasma citrulline  (IAGP)
Microcephaly  (IAGP)
Mitochondrial inheritance  (IAGP)
Mitochondrial myopathy  (IAGP)
Mitochondrial respiratory chain defects  (IAGP)
Multiple glomerular cysts  (IAGP)
Muscle weakness  (IAGP)
Myopathy  (IAGP)
Nystagmus  (IAGP)
Ophthalmoparesis  (IAGP)
Optic atrophy  (IAGP)
Optic disc pallor  (IAGP)
Optic neuropathy  (IAGP)
Paroxysmal involuntary eye movements  (IAGP)
Peripheral neuropathy  (IAGP)
Pigmentary retinopathy  (IAGP)
Polyneuropathy  (IAGP)
Poor eye contact  (IAGP)
Poor head control  (IAGP)
Postural tremor  (IAGP)
Proximal tubulopathy  (IAGP)
Ptosis  (IAGP)
Ragged-red muscle fibers  (IAGP)
Respiratory insufficiency  (IAGP)
Retinal telangiectasia  (IAGP)
Retinal vascular tortuosity  (IAGP)
Rod-cone dystrophy  (IAGP)
Segmental peripheral demyelination/remyelination  (IAGP)
Seizure  (IAGP)
Sensorimotor neuropathy  (IAGP)
Sensorineural hearing impairment  (IAGP)
Severe global developmental delay  (IAGP)
Slow decrease in visual acuity  (IAGP)
Spasticity  (IAGP)
Strabismus  (IAGP)
Ventricular preexcitation  (IAGP)
Visual loss  (IAGP)
Vomiting  (IAGP)
References

Additional References at PubMed
PMID:3921850   PMID:9475751   PMID:11573146   PMID:11735027   PMID:12039661   PMID:12086702   PMID:12111463   PMID:12520145   PMID:12611891   PMID:12782420   PMID:14604458   PMID:14688809  
PMID:15068427   PMID:15069201   PMID:15211636   PMID:15680405   PMID:15680495   PMID:15888325   PMID:15931342   PMID:15975594   PMID:16271520   PMID:16520888   PMID:16763358   PMID:16784756  
PMID:16897192   PMID:16996290   PMID:17277043   PMID:17510502   PMID:17541740   PMID:17636359   PMID:17684475   PMID:17717444   PMID:18031868   PMID:18082471   PMID:18197537   PMID:18461138  
PMID:18514404   PMID:18546119   PMID:18626009   PMID:18679013   PMID:18684894   PMID:19050702   PMID:19077432   PMID:19667492   PMID:19758471   PMID:20301353   PMID:20301403   PMID:21702983  
PMID:22262461   PMID:22351520   PMID:22505229   PMID:24344204   PMID:24612979   PMID:25505242   PMID:25640309   PMID:26179426   PMID:26663065   PMID:28380382   PMID:28494837   PMID:28514442  
PMID:29577757   PMID:31932471   PMID:32652230   PMID:32877691   PMID:33961781  


Genomics

Comparative Map Data
MT-ND2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38.p13 EnsemblMT4,470 - 5,511 (+)EnsemblGRCh38hg38GRCh38
GRCh38MT4,470 - 5,511 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh37MT4,470 - 5,511 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36MT4,471 - 5,512 (+)NCBINCBI36hg18NCBI36
mt-Nd2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39MT3,914 - 4,951 (+)NCBIGRCm39mm39
GRCm39 EnsemblMT3,914 - 4,951 (+)Ensembl
GRCm38MT3,914 - 4,951 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 EnsemblMT3,914 - 4,951 (+)EnsemblGRCm38mm10GRCm38
MGSCv37MT3,914 - 4,951 (+)NCBIGRCm37mm9NCBIm37
Mt-nd2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.2MT3,904 - 4,942 (+)NCBImRatBN7.2
mRatBN7.2 EnsemblMT3,904 - 4,942 (+)Ensembl
Rnor_6.0MT3,904 - 4,942 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 EnsemblMT3,904 - 4,942 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0MT3,904 - 4,942 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4MT3,904 - 4,942 (+)NCBIRGSC3.4rn4RGSC3.4
Cytogenetic MapMT NCBI
MT-ND2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1MT3,914 - 4,955 (+)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 EnsemblMT3,914 - 4,957 (+)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_TashaMT3,914 - 4,955 (+)NCBI
ND2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 EnsemblMT5,087 - 6,128 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1MT5,087 - 6,128 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2MT5,087 - 6,128 (+)NCBISscrofa10.2Sscrofa10.2susScr3

Position Markers
D17S1473E  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37MT3,740 - 3,834UniSTSGRCh37
Cytogenetic Map17p12UniSTS
Cytogenetic Map13q14UniSTS
PMC113853P1  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37MT4,481 - 5,456UniSTSGRCh37
GRCh371565,031 - 566,006UniSTSGRCh37
Build 361554,894 - 555,869RGDNCBI36
HuRef11,286 - 2,261UniSTS
PMC31832P1  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37MT2,806 - 2,946UniSTSGRCh37
GRCh371110,529,460 - 10,529,600UniSTSGRCh37
Build 361110,486,036 - 10,486,176RGDNCBI36
Celera1110,651,202 - 10,651,342RGD
Cytogenetic Map6p21.2UniSTS
Cytogenetic Map2q32.3UniSTS
Cytogenetic Map11p15UniSTS
Cytogenetic Map11p15.3UniSTS
Cytogenetic Map6q24.2UniSTS
PMC55343P1  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37MT4,189 - 4,813UniSTSGRCh37
GRCh371564,739 - 565,363UniSTSGRCh37
Build 361554,602 - 555,226RGDNCBI36
HuRef1994 - 1,618UniSTS
NIB250  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh371110,529,522 - 10,529,694UniSTSGRCh37
GRCh37MT2,712 - 2,884UniSTSGRCh37
Build 361110,486,098 - 10,486,270RGDNCBI36
Celera1110,651,264 - 10,651,436RGD
Cytogenetic Map11p15.3UniSTS
Cytogenetic Map6p21.2UniSTS
Cytogenetic Map6q24.2UniSTS
Stanford-G3 RH Map11334.0UniSTS
GeneMap99-G3 RH Map11334.0UniSTS

miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:126
Count of miRNA genes:122
Interacting mature miRNAs:125
Transcripts:ENST00000361453
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system adipose tissue appendage entire extraembryonic component
High 2429 2865 1719 622 1811 464 4353 2189 3707 416 1442 1606 171 1204 2787 3
Medium 3 119 4 137 2 4 1 2 6 2 1 1
Low
Below cutoff

Sequence

Nucleotide Sequences
GenBank Nucleotide J01415 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENST00000361453   ⟹   ENSP00000355046
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 EnsemblMT4,470 - 5,511 (+)Ensembl
Protein Sequences
Protein RefSeqs YP_003024027 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAB58944 (Get FASTA)   NCBI Sequence Viewer  
  P03891 (Get FASTA)   NCBI Sequence Viewer  
Reference Sequences
RefSeq Acc Id: ENSP00000355046   ⟸   ENST00000361453
Protein Domains
NADH_dehy_S2_C   Proton_antipo_M


Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
m.5244G>A single nucleotide variant Leber hereditary optic neuropathy [RCV000010365] ChrMT:5244 [GRCh38]
ChrMT:5244 [GRCh37]
pathogenic
m.4640C>A single nucleotide variant Leber hereditary optic neuropathy [RCV000010366]|Leigh syndrome [RCV000853787] ChrMT:4640 [GRCh38]
ChrMT:4640 [GRCh37]
pathogenic|benign
m.4917A>G single nucleotide variant Leber hereditary optic neuropathy [RCV000010364]|Leigh syndrome [RCV000853834] ChrMT:4917 [GRCh38]
ChrMT:4917 [GRCh37]
benign|uncertain significance
m.5132_5133delAA deletion Mitochondrial complex I deficiency [RCV000010367] ChrMT:5132..5133 [GRCh38]
ChrMT:5132..5133 [GRCh37]
pathogenic
m.4810G>A single nucleotide variant Mitochondrial complex I deficiency [RCV000010368] ChrMT:4810 [GRCh38]
ChrMT:4810 [GRCh37]
pathogenic
m.4681T>C single nucleotide variant Leigh syndrome [RCV000144022]|Leigh syndrome due to mitochondrial complex I deficiency [RCV000010369] ChrMT:4681 [GRCh38]
ChrMT:4681 [GRCh37]
pathogenic
NC_012920.1:m.5177G>A single nucleotide variant not provided [RCV000513847] ChrMT:5177 [GRCh38]
ChrMT:5177 [GRCh37]
likely benign
NC_012920.1:m.4823T>C single nucleotide variant not provided [RCV000224088] ChrMT:4823 [GRCh38]
ChrMT:4823 [GRCh37]
likely benign
NC_012920.1:m.4733T>C single nucleotide variant not provided [RCV000224092] ChrMT:4733 [GRCh38]
ChrMT:4733 [GRCh37]
likely benign
NC_012920.1:m.5302T>C single nucleotide variant Leigh syndrome [RCV000853891]|not provided [RCV000224519] ChrMT:5302 [GRCh38]
ChrMT:5302 [GRCh37]
benign
NC_012920.1:m.4688T>C single nucleotide variant not provided [RCV000224763] ChrMT:4688 [GRCh38]
ChrMT:4688 [GRCh37]
likely benign
NC_012920.1:m.5033A>G single nucleotide variant not provided [RCV000224839] ChrMT:5033 [GRCh38]
ChrMT:5033 [GRCh37]
likely benign
NC_012920.1:m.5465T>C single nucleotide variant not provided [RCV000224866] ChrMT:5465 [GRCh38]
ChrMT:5465 [GRCh37]
benign
NC_012920.1:m.4768T>C single nucleotide variant not provided [RCV000224931] ChrMT:4768 [GRCh38]
ChrMT:4768 [GRCh37]
uncertain significance
NC_012920.1:m.4597T>C single nucleotide variant not provided [RCV000757486] ChrMT:4597 [GRCh38]
ChrMT:4597 [GRCh37]
uncertain significance
NC_012920.1:m.4664C>T single nucleotide variant Epilepsy [RCV000408951] ChrMT:4664 [GRCh38]
ChrMT:4664 [GRCh37]
uncertain significance
NC_012920.1:m.5105T>C single nucleotide variant not provided [RCV000418463] ChrMT:5105 [GRCh38]
ChrMT:5105 [GRCh37]
uncertain significance
NC_012920.1:m.4472T>C single nucleotide variant not provided [RCV000426698] ChrMT:4472 [GRCh38]
ChrMT:4472 [GRCh37]
uncertain significance
NC_012920.1:m.4769A>G single nucleotide variant not provided [RCV000509491] ChrMT:4769 [GRCh38]
ChrMT:4769 [GRCh37]
not provided
NC_012920.1:m.4983C>T single nucleotide variant not provided [RCV000508415] ChrMT:4983 [GRCh38]
ChrMT:4983 [GRCh37]
likely pathogenic
NC_012920.1:m.5505A>G single nucleotide variant Leigh syndrome [RCV000853916]|not provided [RCV000709825] ChrMT:5505 [GRCh38]
ChrMT:5505 [GRCh37]
uncertain significance|not provided
NC_012920.1:m.4480T>C single nucleotide variant Leigh syndrome [RCV000853760] ChrMT:4480 [GRCh38]
ChrMT:4480 [GRCh37]
uncertain significance
NC_012920.1:m.4488C>T single nucleotide variant Leigh syndrome [RCV000853762] ChrMT:4488 [GRCh38]
ChrMT:4488 [GRCh37]
uncertain significance
NC_012920.1:m.4495T>C single nucleotide variant Leigh syndrome [RCV000853765] ChrMT:4495 [GRCh38]
ChrMT:4495 [GRCh37]
uncertain significance
NC_012920.1:m.4503A>T single nucleotide variant Leigh syndrome [RCV000853769] ChrMT:4503 [GRCh38]
ChrMT:4503 [GRCh37]
uncertain significance
NC_012920.1:m.4531C>T single nucleotide variant Leigh syndrome [RCV000853774] ChrMT:4531 [GRCh38]
ChrMT:4531 [GRCh37]
likely benign
NC_012920.1:m.4554A>G single nucleotide variant Leigh syndrome [RCV000853776] ChrMT:4554 [GRCh38]
ChrMT:4554 [GRCh37]
uncertain significance
NC_012920.1:m.4611del deletion Leigh syndrome [RCV000853781] ChrMT:4605 [GRCh38]
ChrMT:4605 [GRCh37]
likely pathogenic
NC_012920.1:m.4639T>C single nucleotide variant Leigh syndrome [RCV000853786] ChrMT:4639 [GRCh38]
ChrMT:4639 [GRCh37]
benign
NC_012920.1:m.4665G>A single nucleotide variant Leigh syndrome [RCV000853791] ChrMT:4665 [GRCh38]
ChrMT:4665 [GRCh37]
uncertain significance
NC_012920.1:m.4676C>A single nucleotide variant Leigh syndrome [RCV000853793] ChrMT:4676 [GRCh38]
ChrMT:4676 [GRCh37]
uncertain significance
NC_012920.1:m.4702A>G single nucleotide variant Leigh syndrome [RCV000853799] ChrMT:4702 [GRCh38]
ChrMT:4702 [GRCh37]
likely benign
NC_012920.1:m.4734A>G single nucleotide variant Leigh syndrome [RCV000853808] ChrMT:4734 [GRCh38]
ChrMT:4734 [GRCh37]
benign
NC_012920.1:m.4735C>A single nucleotide variant Leigh syndrome [RCV000853809] ChrMT:4735 [GRCh38]
ChrMT:4735 [GRCh37]
benign
NC_012920.1:m.4776G>A single nucleotide variant Leigh syndrome [RCV000853821] ChrMT:4776 [GRCh38]
ChrMT:4776 [GRCh37]
uncertain significance
NC_012920.1:m.4788G>A single nucleotide variant Leigh syndrome [RCV000853822] ChrMT:4788 [GRCh38]
ChrMT:4788 [GRCh37]
uncertain significance
NC_012920.1:m.4843C>T single nucleotide variant Leigh syndrome [RCV000853829] ChrMT:4843 [GRCh38]
ChrMT:4843 [GRCh37]
benign
NC_012920.1:m.4911T>G single nucleotide variant Leigh syndrome [RCV000853833] ChrMT:4911 [GRCh38]
ChrMT:4911 [GRCh37]
likely benign
NC_012920.1:m.4959G>A single nucleotide variant Leigh syndrome [RCV000853846] ChrMT:4959 [GRCh38]
ChrMT:4959 [GRCh37]
benign
NC_012920.1:m.4960C>T single nucleotide variant Leigh syndrome [RCV000853847] ChrMT:4960 [GRCh38]
ChrMT:4960 [GRCh37]
benign
NC_012920.1:m.5001dup duplication Leigh syndrome [RCV000853850] ChrMT:4997..4998 [GRCh38]
ChrMT:4997..4998 [GRCh37]
pathogenic
NC_012920.1:m.5010T>C single nucleotide variant Leigh syndrome [RCV000853851] ChrMT:5010 [GRCh38]
ChrMT:5010 [GRCh37]
uncertain significance
NC_012920.1:m.5046G>A single nucleotide variant Leigh syndrome [RCV000853853] ChrMT:5046 [GRCh38]
ChrMT:5046 [GRCh37]
benign
NC_012920.1:m.5069A>T single nucleotide variant Leigh syndrome [RCV000853856] ChrMT:5069 [GRCh38]
ChrMT:5069 [GRCh37]
likely benign
NC_012920.1:m.5074T>C single nucleotide variant Leigh syndrome [RCV000853858] ChrMT:5074 [GRCh38]
ChrMT:5074 [GRCh37]
benign
NC_012920.1:m.5127A>G single nucleotide variant Leigh syndrome [RCV000853864] ChrMT:5127 [GRCh38]
ChrMT:5127 [GRCh37]
likely benign
NC_012920.1:m.5149C>T single nucleotide variant Leigh syndrome [RCV000853866] ChrMT:5149 [GRCh38]
ChrMT:5149 [GRCh37]
likely benign
NC_012920.1:m.5178C>A single nucleotide variant Leigh syndrome [RCV000853868] ChrMT:5178 [GRCh38]
ChrMT:5178 [GRCh37]
benign
NC_012920.1:m.5191C>T single nucleotide variant Leigh syndrome [RCV000853871] ChrMT:5191 [GRCh38]
ChrMT:5191 [GRCh37]
likely benign
NC_012920.1:m.5194C>T single nucleotide variant Leigh syndrome [RCV000853872] ChrMT:5194 [GRCh38]
ChrMT:5194 [GRCh37]
benign
NC_012920.1:m.5205T>C single nucleotide variant Leigh syndrome [RCV000853873] ChrMT:5205 [GRCh38]
ChrMT:5205 [GRCh37]
likely benign
NC_012920.1:m.5263C>T single nucleotide variant Leigh syndrome [RCV000853877] ChrMT:5263 [GRCh38]
ChrMT:5263 [GRCh37]
benign
NC_012920.1:m.5277T>C single nucleotide variant Leigh syndrome [RCV000853882] ChrMT:5277 [GRCh38]
ChrMT:5277 [GRCh37]
benign
NC_012920.1:m.5295C>A single nucleotide variant Leigh syndrome [RCV000853886] ChrMT:5295 [GRCh38]
ChrMT:5295 [GRCh37]
uncertain significance
NC_012920.1:m.5296T>C single nucleotide variant Leigh syndrome [RCV000853887] ChrMT:5296 [GRCh38]
ChrMT:5296 [GRCh37]
uncertain significance
NC_012920.1:m.5310A>G single nucleotide variant Leigh syndrome [RCV000853892] ChrMT:5310 [GRCh38]
ChrMT:5310 [GRCh37]
uncertain significance
NC_012920.1:m.5320C>T single nucleotide variant Leigh syndrome [RCV000853898] ChrMT:5320 [GRCh38]
ChrMT:5320 [GRCh37]
likely benign
NC_012920.1:m.5325A>G single nucleotide variant Leigh syndrome [RCV000853899] ChrMT:5325 [GRCh38]
ChrMT:5325 [GRCh37]
uncertain significance
NC_012920.1:m.5493T>C single nucleotide variant Leigh syndrome [RCV000853913] ChrMT:5493 [GRCh38]
ChrMT:5493 [GRCh37]
benign
NC_012920.1:m.5494T>G single nucleotide variant Leigh syndrome [RCV000853914] ChrMT:5494 [GRCh38]
ChrMT:5494 [GRCh37]
likely benign
NC_012920.1:m.4491G>A single nucleotide variant Leigh syndrome [RCV000853763] ChrMT:4491 [GRCh38]
ChrMT:4491 [GRCh37]
benign
NC_012920.1:m.4579T>C single nucleotide variant Leigh syndrome [RCV000853779] ChrMT:4579 [GRCh38]
ChrMT:4579 [GRCh37]
uncertain significance
NC_012920.1:m.4659G>T single nucleotide variant Leigh syndrome [RCV000853790] ChrMT:4659 [GRCh38]
ChrMT:4659 [GRCh37]
uncertain significance
NC_012920.1:m.4689A>G single nucleotide variant Leigh syndrome [RCV000853795] ChrMT:4689 [GRCh38]
ChrMT:4689 [GRCh37]
likely benign
NC_012920.1:m.4696T>C single nucleotide variant Leigh syndrome [RCV000853798] ChrMT:4696 [GRCh38]
ChrMT:4696 [GRCh37]
benign
NC_012920.1:m.4707C>T single nucleotide variant Leigh syndrome [RCV000853801] ChrMT:4707 [GRCh38]
ChrMT:4707 [GRCh37]
benign
NC_012920.1:m.4767A>G single nucleotide variant Leigh syndrome [RCV000853818] ChrMT:4767 [GRCh38]
ChrMT:4767 [GRCh37]
benign
NC_012920.1:m.4812G>C single nucleotide variant Leigh syndrome [RCV000853824] ChrMT:4812 [GRCh38]
ChrMT:4812 [GRCh37]
likely benign
NC_012920.1:m.4908C>T single nucleotide variant Leigh syndrome [RCV000853832] ChrMT:4908 [GRCh38]
ChrMT:4908 [GRCh37]
likely benign
NC_012920.1:m.4924G>A single nucleotide variant Leigh syndrome [RCV000853837] ChrMT:4924 [GRCh38]
ChrMT:4924 [GRCh37]
benign
NC_012920.1:m.4929C>T single nucleotide variant Leigh syndrome [RCV000853838] ChrMT:4929 [GRCh38]
ChrMT:4929 [GRCh37]
uncertain significance
NC_012920.1:m.4935A>C single nucleotide variant Leigh syndrome [RCV000853839] ChrMT:4935 [GRCh38]
ChrMT:4935 [GRCh37]
uncertain significance
NC_012920.1:m.4935A>G single nucleotide variant Leigh syndrome [RCV000853840]|Mitochondrial diseases [RCV001090168] ChrMT:4935 [GRCh38]
ChrMT:4935 [GRCh37]
uncertain significance
NC_012920.1:m.4954T>C single nucleotide variant Leigh syndrome [RCV000853845] ChrMT:4954 [GRCh38]
ChrMT:4954 [GRCh37]
uncertain significance
NC_012920.1:m.4509T>C single nucleotide variant Leigh syndrome [RCV000853771] ChrMT:4509 [GRCh38]
ChrMT:4509 [GRCh37]
uncertain significance
NC_012920.1:m.4632G>A single nucleotide variant Leigh syndrome [RCV000853784] ChrMT:4632 [GRCh38]
ChrMT:4632 [GRCh37]
uncertain significance
NC_012920.1:m.4638A>G single nucleotide variant Leigh syndrome [RCV000853785] ChrMT:4638 [GRCh38]
ChrMT:4638 [GRCh37]
uncertain significance
NC_012920.1:m.4659G>A single nucleotide variant Leigh syndrome [RCV000853789] ChrMT:4659 [GRCh38]
ChrMT:4659 [GRCh37]
benign
NC_012920.1:m.4674A>G single nucleotide variant Leigh syndrome [RCV000853792] ChrMT:4674 [GRCh38]
ChrMT:4674 [GRCh37]
benign
NC_012920.1:m.4680C>A single nucleotide variant Leigh syndrome [RCV000853794] ChrMT:4680 [GRCh38]
ChrMT:4680 [GRCh37]
uncertain significance
NC_012920.1:m.4695T>C single nucleotide variant Leigh syndrome [RCV000853797] ChrMT:4695 [GRCh38]
ChrMT:4695 [GRCh37]
benign
NC_012920.1:m.4717A>T single nucleotide variant Leigh syndrome [RCV000853802] ChrMT:4717 [GRCh38]
ChrMT:4717 [GRCh37]
uncertain significance
NC_012920.1:m.4725A>T single nucleotide variant Leigh syndrome [RCV000853804] ChrMT:4725 [GRCh38]
ChrMT:4725 [GRCh37]
likely benign
NC_012920.1:m.4732A>G single nucleotide variant Leigh syndrome [RCV000853807] ChrMT:4732 [GRCh38]
ChrMT:4732 [GRCh37]
benign
NC_012920.1:m.4764A>G single nucleotide variant Leigh syndrome [RCV000853816] ChrMT:4764 [GRCh38]
ChrMT:4764 [GRCh37]
uncertain significance
NC_012920.1:m.4770G>A single nucleotide variant Leigh syndrome [RCV000853820] ChrMT:4770 [GRCh38]
ChrMT:4770 [GRCh37]
uncertain significance
NC_012920.1:m.4894T>C single nucleotide variant Leigh syndrome [RCV000853830] ChrMT:4894 [GRCh38]
ChrMT:4894 [GRCh37]
uncertain significance
NC_012920.1:m.4936C>T single nucleotide variant Leigh syndrome [RCV000853841] ChrMT:4936 [GRCh38]
ChrMT:4936 [GRCh37]
benign
NC_012920.1:m.5038T>C single nucleotide variant Leigh syndrome [RCV000853852] ChrMT:5038 [GRCh38]
ChrMT:5038 [GRCh37]
uncertain significance
NC_012920.1:m.5047T>C single nucleotide variant Leigh syndrome [RCV000853854] ChrMT:5047 [GRCh38]
ChrMT:5047 [GRCh37]
uncertain significance
NC_012920.1:m.5094A>G single nucleotide variant Leigh syndrome [RCV000853862] ChrMT:5094 [GRCh38]
ChrMT:5094 [GRCh37]
uncertain significance
NC_012920.1:m.5186A>T single nucleotide variant Leigh syndrome [RCV000853869] ChrMT:5186 [GRCh38]
ChrMT:5186 [GRCh37]
benign
NC_012920.1:m.5460G>A single nucleotide variant Leigh syndrome [RCV000853909] ChrMT:5460 [GRCh38]
ChrMT:5460 [GRCh37]
benign
NC_012920.1:m.5484A>G single nucleotide variant Leigh syndrome [RCV000853912] ChrMT:5484 [GRCh38]
ChrMT:5484 [GRCh37]
likely benign
NC_012920.1:m.4974G>A single nucleotide variant Leigh syndrome [RCV000853849] ChrMT:4974 [GRCh38]
ChrMT:4974 [GRCh37]
uncertain significance
NC_012920.1:m.5067A>G single nucleotide variant Leigh syndrome [RCV000853855] ChrMT:5067 [GRCh38]
ChrMT:5067 [GRCh37]
likely benign
NC_012920.1:m.5206C>T single nucleotide variant Leigh syndrome [RCV000853874] ChrMT:5206 [GRCh38]
ChrMT:5206 [GRCh37]
benign
NC_012920.1:m.5265A>G single nucleotide variant Leigh syndrome [RCV000853878] ChrMT:5265 [GRCh38]
ChrMT:5265 [GRCh37]
uncertain significance
NC_012920.1:m.5273A>T single nucleotide variant Leigh syndrome [RCV000853881] ChrMT:5273 [GRCh38]
ChrMT:5273 [GRCh37]
likely benign
NC_012920.1:m.5289A>G single nucleotide variant Leigh syndrome [RCV000853883] ChrMT:5289 [GRCh38]
ChrMT:5289 [GRCh37]
uncertain significance
NC_012920.1:m.5293G>A single nucleotide variant Leigh syndrome [RCV000853884] ChrMT:5293 [GRCh38]
ChrMT:5293 [GRCh37]
likely benign
NC_012920.1:m.5298A>G single nucleotide variant Leigh syndrome [RCV000853888] ChrMT:5298 [GRCh38]
ChrMT:5298 [GRCh37]
likely benign
NC_012920.1:m.5301A>G single nucleotide variant Leigh syndrome [RCV000853889] ChrMT:5301 [GRCh38]
ChrMT:5301 [GRCh37]
benign
NC_012920.1:m.5319A>G single nucleotide variant Leigh syndrome [RCV000853895] ChrMT:5319 [GRCh38]
ChrMT:5319 [GRCh37]
benign
NC_012920.1:m.5319A>T single nucleotide variant Leigh syndrome [RCV000853896] ChrMT:5319 [GRCh38]
ChrMT:5319 [GRCh37]
likely benign
NC_012920.1:m.5331C>G single nucleotide variant Leigh syndrome [RCV000853902] ChrMT:5331 [GRCh38]
ChrMT:5331 [GRCh37]
likely benign
NC_012920.1:m.5452C>T single nucleotide variant Leigh syndrome [RCV000853908] ChrMT:5452 [GRCh38]
ChrMT:5452 [GRCh37]
likely benign
NC_012920.1:m.5496A>G single nucleotide variant Leigh syndrome [RCV000853915] ChrMT:5496 [GRCh38]
ChrMT:5496 [GRCh37]
uncertain significance
NC_012920.1:m.4494A>G single nucleotide variant Leigh syndrome [RCV000853764] ChrMT:4494 [GRCh38]
ChrMT:4494 [GRCh37]
uncertain significance
NC_012920.1:m.4500T>C single nucleotide variant Leigh syndrome [RCV000853767] ChrMT:4500 [GRCh38]
ChrMT:4500 [GRCh37]
likely benign
NC_012920.1:m.4506A>G single nucleotide variant Leigh syndrome [RCV000853770] ChrMT:4506 [GRCh38]
ChrMT:4506 [GRCh37]
benign
NC_012920.1:m.4513C>T single nucleotide variant Leigh syndrome [RCV000853773] ChrMT:4513 [GRCh38]
ChrMT:4513 [GRCh37]
uncertain significance
NC_012920.1:m.4561T>C single nucleotide variant Leigh syndrome [RCV000853778] ChrMT:4561 [GRCh38]
ChrMT:4561 [GRCh37]
benign
NC_012920.1:m.4596G>A single nucleotide variant Leigh syndrome [RCV000853780] ChrMT:4596 [GRCh38]
ChrMT:4596 [GRCh37]
benign
NC_012920.1:m.4612T>C single nucleotide variant Leigh syndrome [RCV000853782] ChrMT:4612 [GRCh38]
ChrMT:4612 [GRCh37]
likely benign
NC_012920.1:m.4705T>C single nucleotide variant Leigh syndrome [RCV000853800] ChrMT:4705 [GRCh38]
ChrMT:4705 [GRCh37]
benign
NC_012920.1:m.4722A>G single nucleotide variant Leigh syndrome [RCV000853803] ChrMT:4722 [GRCh38]
ChrMT:4722 [GRCh37]
benign
NC_012920.1:m.4725A>C single nucleotide variant Leigh syndrome [RCV000853805] ChrMT:4725 [GRCh38]
ChrMT:4725 [GRCh37]
likely benign
NC_012920.1:m.4749T>C single nucleotide variant Leigh syndrome [RCV000853812] ChrMT:4749 [GRCh38]
ChrMT:4749 [GRCh37]
uncertain significance
NC_012920.1:m.4768_4769delinsCG indel Leigh syndrome [RCV000853819] ChrMT:4768..4769 [GRCh38]
ChrMT:4768..4769 [GRCh37]
uncertain significance
NC_012920.1:m.4789G>A single nucleotide variant Leigh syndrome [RCV000853823] ChrMT:4789 [GRCh38]
ChrMT:4789 [GRCh37]
uncertain significance
NC_012920.1:m.4812G>A single nucleotide variant Leigh syndrome [RCV000853825] ChrMT:4812 [GRCh38]
ChrMT:4812 [GRCh37]
likely benign
NC_012920.1:m.4824A>G single nucleotide variant Leigh syndrome [RCV000853826] ChrMT:4824 [GRCh38]
ChrMT:4824 [GRCh37]
benign
NC_012920.1:m.4902A>G single nucleotide variant Leigh syndrome [RCV000853831] ChrMT:4902 [GRCh38]
ChrMT:4902 [GRCh37]
uncertain significance
NC_012920.1:m.4953A>G single nucleotide variant Leigh syndrome [RCV000853844] ChrMT:4953 [GRCh38]
ChrMT:4953 [GRCh37]
uncertain significance
NC_012920.1:m.5080A>G single nucleotide variant Leigh syndrome [RCV000853860] ChrMT:5080 [GRCh38]
ChrMT:5080 [GRCh37]
uncertain significance
NC_012920.1:m.5166A>G single nucleotide variant Leigh syndrome [RCV000853867] ChrMT:5166 [GRCh38]
ChrMT:5166 [GRCh37]
likely benign
NC_012920.1:m.5301A>C single nucleotide variant Leigh syndrome [RCV000853890] ChrMT:5301 [GRCh38]
ChrMT:5301 [GRCh37]
uncertain significance
NC_012920.1:m.5311T>C single nucleotide variant Leigh syndrome [RCV000853893] ChrMT:5311 [GRCh38]
ChrMT:5311 [GRCh37]
uncertain significance
NC_012920.1:m.5331C>A single nucleotide variant Leigh syndrome [RCV000853901] ChrMT:5331 [GRCh38]
ChrMT:5331 [GRCh37]
benign
NC_012920.1:m.5442T>C single nucleotide variant Leigh syndrome [RCV000853905] ChrMT:5442 [GRCh38]
ChrMT:5442 [GRCh37]
benign
NC_012920.1:m.4482G>A single nucleotide variant Leigh syndrome [RCV000853761] ChrMT:4482 [GRCh38]
ChrMT:4482 [GRCh37]
uncertain significance
NC_012920.1:m.4548T>C single nucleotide variant Leigh syndrome [RCV000853775] ChrMT:4548 [GRCh38]
ChrMT:4548 [GRCh37]
uncertain significance
NC_012920.1:m.4560G>A single nucleotide variant Leigh syndrome [RCV000853777] ChrMT:4560 [GRCh38]
ChrMT:4560 [GRCh37]
benign
NC_012920.1:m.4654C>T single nucleotide variant Leigh syndrome [RCV000853788] ChrMT:4654 [GRCh38]
ChrMT:4654 [GRCh37]
likely benign
NC_012920.1:m.4728A>G single nucleotide variant Leigh syndrome [RCV000853806] ChrMT:4728 [GRCh38]
ChrMT:4728 [GRCh37]
likely benign
NC_012920.1:m.4762T>C single nucleotide variant Leigh syndrome [RCV000853814] ChrMT:4762 [GRCh38]
ChrMT:4762 [GRCh37]
likely benign
NC_012920.1:m.4763C>A single nucleotide variant Leigh syndrome [RCV000853815] ChrMT:4763 [GRCh38]
ChrMT:4763 [GRCh37]
likely benign
NC_012920.1:m.4924G>C single nucleotide variant Leigh syndrome [RCV000853836] ChrMT:4924 [GRCh38]
ChrMT:4924 [GRCh37]
likely benign
NC_012920.1:m.4948T>C single nucleotide variant Leigh syndrome [RCV000853843] ChrMT:4948 [GRCh38]
ChrMT:4948 [GRCh37]
uncertain significance
NC_012920.1:m.4965A>G single nucleotide variant Leigh syndrome [RCV000853848] ChrMT:4965 [GRCh38]
ChrMT:4965 [GRCh37]
benign
NC_012920.1:m.5073A>G single nucleotide variant Leigh syndrome [RCV000853857] ChrMT:5073 [GRCh38]
ChrMT:5073 [GRCh37]
likely benign
NC_012920.1:m.5076C>T single nucleotide variant Leigh syndrome [RCV000853859] ChrMT:5076 [GRCh38]
ChrMT:5076 [GRCh37]
benign
NC_012920.1:m.5128A>G single nucleotide variant Leigh syndrome [RCV000853865] ChrMT:5128 [GRCh38]
ChrMT:5128 [GRCh37]
likely benign
NC_012920.1:m.5190A>G single nucleotide variant Leigh syndrome [RCV000853870] ChrMT:5190 [GRCh38]
ChrMT:5190 [GRCh37]
uncertain significance
NC_012920.1:m.5262G>A single nucleotide variant Leigh syndrome [RCV000853876] ChrMT:5262 [GRCh38]
ChrMT:5262 [GRCh37]
benign
NC_012920.1:m.5266T>C single nucleotide variant Leigh syndrome [RCV000853879] ChrMT:5266 [GRCh38]
ChrMT:5266 [GRCh37]
uncertain significance
NC_012920.1:m.5268A>G single nucleotide variant Leigh syndrome [RCV000853880] ChrMT:5268 [GRCh38]
ChrMT:5268 [GRCh37]
likely benign
NC_012920.1:m.5316G>A single nucleotide variant Leigh syndrome [RCV000853894] ChrMT:5316 [GRCh38]
ChrMT:5316 [GRCh37]
likely benign
NC_012920.1:m.5320C>G single nucleotide variant Leigh syndrome [RCV000853897] ChrMT:5320 [GRCh38]
ChrMT:5320 [GRCh37]
uncertain significance
NC_012920.1:m.5444C>A single nucleotide variant Leigh syndrome [RCV000853906] ChrMT:5444 [GRCh38]
ChrMT:5444 [GRCh37]
uncertain significance
NC_012920.1:m.5463C>T single nucleotide variant Leigh syndrome [RCV000853910] ChrMT:5463 [GRCh38]
ChrMT:5463 [GRCh37]
benign
NC_012920.1:m.5466A>G single nucleotide variant Leigh syndrome [RCV000853911] ChrMT:5466 [GRCh38]
ChrMT:5466 [GRCh37]
benign
NC_012920.1:m.4497T>C single nucleotide variant Leigh syndrome [RCV000853766] ChrMT:4497 [GRCh38]
ChrMT:4497 [GRCh37]
uncertain significance
NC_012920.1:m.4501C>T single nucleotide variant Leigh syndrome [RCV000853768] ChrMT:4501 [GRCh38]
ChrMT:4501 [GRCh37]
benign
NC_012920.1:m.4512G>A single nucleotide variant Leigh syndrome [RCV000853772] ChrMT:4512 [GRCh38]
ChrMT:4512 [GRCh37]
benign
NC_012920.1:m.4615A>G single nucleotide variant Leigh syndrome [RCV000853783] ChrMT:4615 [GRCh38]
ChrMT:4615 [GRCh37]
benign
NC_012920.1:m.4690T>C single nucleotide variant Leigh syndrome [RCV000853796] ChrMT:4690 [GRCh38]
ChrMT:4690 [GRCh37]
uncertain significance
NC_012920.1:m.4745A>T single nucleotide variant Leigh syndrome [RCV000853810] ChrMT:4745 [GRCh38]
ChrMT:4745 [GRCh37]
uncertain significance
NC_012920.1:m.4746T>C single nucleotide variant Leigh syndrome [RCV000853811] ChrMT:4746 [GRCh38]
ChrMT:4746 [GRCh37]
uncertain significance
NC_012920.1:m.4759T>C single nucleotide variant Leigh syndrome [RCV000853813] ChrMT:4759 [GRCh38]
ChrMT:4759 [GRCh37]
uncertain significance
NC_012920.1:m.4765T>C single nucleotide variant Leigh syndrome [RCV000853817] ChrMT:4765 [GRCh38]
ChrMT:4765 [GRCh37]
uncertain significance
NC_012920.1:m.4833A>G single nucleotide variant Leigh syndrome [RCV000853827] ChrMT:4833 [GRCh38]
ChrMT:4833 [GRCh37]
benign
NC_012920.1:m.4842A>G single nucleotide variant Leigh syndrome [RCV000853828] ChrMT:4842 [GRCh38]
ChrMT:4842 [GRCh37]
likely benign
NC_012920.1:m.4923A>T single nucleotide variant Leigh syndrome [RCV000853835] ChrMT:4923 [GRCh38]
ChrMT:4923 [GRCh37]
uncertain significance
NC_012920.1:m.4944A>G single nucleotide variant Leigh syndrome [RCV000853842] ChrMT:4944 [GRCh38]
ChrMT:4944 [GRCh37]
likely benign
NC_012920.1:m.5086C>T single nucleotide variant Leigh syndrome [RCV000853861] ChrMT:5086 [GRCh38]
ChrMT:5086 [GRCh37]
likely benign
NC_012920.1:m.5095T>C single nucleotide variant Leigh syndrome [RCV000853863] ChrMT:5095 [GRCh38]
ChrMT:5095 [GRCh37]
likely benign
NC_012920.1:m.5211C>T single nucleotide variant Leigh syndrome [RCV000853875] ChrMT:5211 [GRCh38]
ChrMT:5211 [GRCh37]
benign
NC_012920.1:m.5295C>T single nucleotide variant Leigh syndrome [RCV000853885] ChrMT:5295 [GRCh38]
ChrMT:5295 [GRCh37]
likely benign
NC_012920.1:m.5325A>T single nucleotide variant Leigh syndrome [RCV000853900] ChrMT:5325 [GRCh38]
ChrMT:5325 [GRCh37]
likely benign
NC_012920.1:m.5367_5385del deletion Mitochondrial myopathy, infantile, transient [RCV000853903] ChrMT:5360..5378 [GRCh38]
ChrMT:5360..5378 [GRCh37]
likely pathogenic
NC_012920.1:m.5437C>T single nucleotide variant Leigh syndrome [RCV000853904] ChrMT:5437 [GRCh38]
ChrMT:5437 [GRCh37]
benign
NC_012920.1:m.5451A>G single nucleotide variant Leigh syndrome [RCV000853907] ChrMT:5451 [GRCh38]
ChrMT:5451 [GRCh37]
uncertain significance

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:7456 AgrOrtholog
COSMIC MT-ND2 COSMIC
Ensembl Genes ENSG00000198763 Ensembl, UniProtKB/Swiss-Prot
Ensembl Protein ENSP00000355046 ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000361453 UniProtKB/Swiss-Prot
GTEx ENSG00000198763 GTEx
HGNC ID HGNC:7456 ENTREZGENE
Human Proteome Map MT-ND2 Human Proteome Map
InterPro NADH_DH_su2_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  NADH_UbQ_OxRdtase_chain2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ND/Mrp_mem UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:4536 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
NCBI Gene 4536 ENTREZGENE
OMIM 516001 OMIM
Pfam NADH_dehy_S2_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Proton_antipo_M UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA31260 PharmGKB
PRINTS NADHDHGNASE2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A1X7RBG6_HUMAN UniProtKB/TrEMBL
  NU2M_HUMAN UniProtKB/Swiss-Prot, ENTREZGENE
  Q7GXY9 ENTREZGENE, UniProtKB/TrEMBL
UniProt Secondary H9LPT2 UniProtKB/TrEMBL
  H9LQR7 UniProtKB/TrEMBL
  Q34769 UniProtKB/Swiss-Prot
  Q85KS9 UniProtKB/TrEMBL
  Q85KU4 UniProtKB/TrEMBL
  Q85L01 UniProtKB/TrEMBL
  Q9TGI0 UniProtKB/Swiss-Prot
  Q9TGI1 UniProtKB/Swiss-Prot
  Q9TGI2 UniProtKB/Swiss-Prot
  Q9TGI3 UniProtKB/Swiss-Prot
  Q9TGI4 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2020-02-26 MT-ND2  mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2  MT-ND2  mitochondrially encoded NADH dehydrogenase 2  Symbol and/or name change 19259463 PROVISIONAL
2015-05-19 MT-ND2  mitochondrially encoded NADH dehydrogenase 2  ND2    Symbol and/or name change 5135510 APPROVED
2014-01-07 ND2  mitochondrially encoded NADH dehydrogenase 2  MT-ND2    Symbol and/or name change 5135510 APPROVED
2012-10-09 MT-ND2  mitochondrially encoded NADH dehydrogenase 2  ND2    Symbol and/or name change 5135510 APPROVED
2012-07-13 ND2    MT-ND2  mitochondrially encoded NADH dehydrogenase 2  Symbol and/or name change 5135510 APPROVED